Blend Labs vs Cardlytics
BLND and CDLX side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BLND and CDLX compare
Blend Labs is the larger company, worth 26 times as much as Cardlytics ($248M against $9.7M).
Blend Labs grew revenue faster over the last twelve months (6.5% versus −25.3% for Cardlytics).
Blend Labs keeps more of each dollar of sales as profit, with a net margin of −14.2% compared with −20.8% at Cardlytics.
Blend Labs scores higher on the StockData Score (8 against 7 for Cardlytics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BLND | CDLX |
|---|---|---|
| Size and price | ||
| Market cap | $248M | $9.7M |
| Share price | $1.05 | $1.65 |
| Change, 1 year | −65.0% | −88.5% |
| Change, 5 years | −91.0% | −99.8% |
| Beta (5Y) | 1.26 | 2.50 |
| Employees | 419 | 275 |
| StockData Score | ||
| Total score | 8 (better) | 7 |
| Valuation score | 1 | 1 |
| Growth score | 1 (better) | 0 |
| Performance score | 1 | 1 |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.9× | 0.1× (better) |
| P/FCF | 18.5× | – |
| FCF yield | 5.4% (better) | −74.1% |
| Growth | ||
| Revenue growth (TTM) | 6.5% (better) | −25.3% |
| Revenue growth, 5Y average | 5.2% (better) | 4.5% |
| Profitability | ||
| Gross margin | 73.8% | – |
| Operating margin | −10.9% (better) | −19.2% |
| Net margin | −14.2% (better) | −20.8% |
| FCF margin | 10.4% (better) | −4.1% |
| Financial health | ||
| Current ratio | 1.72 | 1.82 (better) |
| Altman Z-score | −9.59 | −8.24 (better) |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Buyback yield | 21.3% | – |
| Shareholder yield | 21.3% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 64.3% | 29.6% |
| Held by insiders | 55.7% | – |
| Insider net buying, 12 months | $15.4M (better) | −$406K |
| Short interest, % of float | 7.1% | – |
Go deeper
- BLND stock overview
- BLND income statement
- BLND valuation and score
- CDLX stock overview
- CDLX income statement
- CDLX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.